Should Gong acquire Avoma in 2027?

The two paths on the table, side by side

Every acquisition question is really a capital-allocation question wearing a costume. The honest framing for Gong in 2027 isn't "is Avoma a good company?" — it plainly is — but "is a $150-300M check for Avoma the best available use of $150-300M given where Gong sits in its lifecycle?" Those are different questions with different answers, and RevOps leaders evaluating any vendor-consolidation move should learn to separate them, because the same confusion shows up when a VP of Sales argues for buying a point solution instead of extending the platform they already own.

Path A — acquire Avoma. Gong writes a check somewhere in the $150-300M range (a defensible 3-10x multiple on Avoma's estimated $10-25M ARR, with the wider $30-60M ARR estimates circulating in secondary-market chatter pushing the top of that band). Gong gets an AI meeting assistant with a mature mid-market motion, an estimated few thousand customers concentrated in 50-500-employee B2B SaaS companies, a HubSpot-heavy CRM integration surface, and an engineering team that has shipped transcription, summarization, topic detection, talk-ratio analytics, scorecards, and CRM sync at a $19-$129/user/month price point. Gong gains a plausible "Gong for SMB" SKU without building one, plus a defensive block against Otter.ai, Fireflies, Fathom, or Read.ai consolidating the category from below.

Path B — decline and redeploy. Gong keeps the capital and spends it against three named alternatives: (1) organic AI agent development for autonomous deal review, coaching-plan generation, and forecast adjustment; (2) vertical AI models for healthcare (HIPAA-compliant redaction), financial services (recording obligations under regimes like MiFID II and FINRA rules), pharma, and legal; (3) selective M&A that actually changes Gong's strategic position — a Chorus buyback if ZoomInfo ever divests, a competitive-intelligence tuck-in like Klue or Crayon, or a genuinely transformational combination with a sales-engagement platform like Outreach or Salesloft.

The core asymmetry: Path A buys revenue Gong could largely build, in a segment Gong doesn't serve well, at a price that buys nothing defensible. Path B buys differentiation in a category Gong already leads. When two paths cost the same and one of them compounds, the one that compounds wins — and AI agents compound on top of Gong's existing conversation corpus in a way a second transcription engine never will.

There is a third path worth naming, because it's the one most acquirers actually take by accident: Path C — do neither, and drift. Gong evaluates Avoma for nine months, ties up corp-dev bandwidth and exec attention, never gets to a price both sides accept, and emerges with nothing but sunk diligence cost right as the S-1 preparation window opens. This is the modal outcome for mid-size strategic M&A discussions and it is strictly worse than a fast, principled no. Deciding quickly is itself a form of capital preservation.

Why the strategic overlap kills the deal

Both companies do conversation intelligence. Both record, transcribe, summarize, extract action items, detect topics, compute talk ratios, score calls, and sync to CRM. Avoma is, functionally, Gong-lite priced for teams that couldn't sign Gong's contract. Acquiring it doesn't fill a gap in the product; it duplicates a surface Gong has spent a decade hardening since Amit Bendov and Eilon Reshef founded the company in 2015.

Walk the feature inventory honestly. Gong Forecast represents years of accumulated conversation signal — deal-stage advancement language, commitment cues, objection patterns, multi-threading depth — fused with CRM data into probabilistic forecasts that enterprise revenue leaders run their weekly deal inspection on. Avoma has forecasting-adjacent features; it does not have that. Gong's Smart Trackers auto-detect competitors, pricing objections, and custom topics with enterprise-grade configurability. Avoma has topic detection; it does not have that depth of tuning or the enterprise admin surface around it. Gong Engage extends into sequencing and outreach to compete with Outreach and Salesloft. Avoma has no equivalent. Gong's vertical AI roadmap is a multi-year differentiation bet. Avoma has no vertical capability at all.

Lay the two maps on top of each other and the honest count of what Avoma adds is short: a mid-market customer list and some engineers. That's it. Every technical capability is a strict subset. The interesting question then becomes whether those two assets alone justify the price — and both fail on inspection.

The customer list fails because those customers are structurally price-sensitive by revealed preference. They evaluated the enterprise tier and chose the $19-$129/user/month option. Gong's effective enterprise pricing runs roughly $1,000-$2,000/user/year — call it $83-$167/user/month — with enterprise contracts commonly landing in the $200K-$5M+ ACV range. A mid-market team paying $29/user/month faces a multiple-fold increase to migrate. Price sensitivity doesn't evaporate on the day the acquisition closes; it hardens into churn.

The engineering talent fails a different test. Acquiring a whole company to get 50-80 engineers is the most expensive form of hiring available, and it comes bundled with a customer base you have to support, a product you have to maintain or sunset, a brand you have to decide about, and a founding team — Aditya Kothadiya, Devang Sachdev, Pratik Vyas — whose retention math is unfavorable. Founder energy in acquired companies reliably decays on a 24-36 month clock. If Gong wants AI/ML talent, the market offers cleaner ways to buy it.

There's an adjacent lesson here that generalizes well beyond this one deal, and it's the reason this question matters to RevOps practitioners who will never sit in a corp-dev meeting. The same overlap analysis applies when a revenue org debates buying a standalone conversation-intelligence tool alongside an existing platform, or a standalone forecasting tool alongside a CRM that forecasts, or a standalone enablement tool alongside an LMS. Map the capability surfaces, count what's genuinely additive, and price only the additive part. Most stack-consolidation arguments collapse the moment someone actually draws that map.

Run Gong plus Avoma through that decision tree and it exits at the first or second gate. Overlap is high, the customer base is not strategically adjacent, and the path terminates in "decline and redeploy." That isn't a close call dressed up as one — it's a clean early exit.

The numbers behind each option

Strategy arguments get slippery without arithmetic, so here is the arithmetic. All figures are estimates from public reporting and market chatter; treat them as ranges, not audited numbers.

Scale mismatch. Gong's ARR is commonly estimated in the $300-400M range as of 2024, with some estimates running to $500M. Avoma's is estimated at $10-25M, with more generous secondary-market estimates reaching $30-60M. Take the midpoints and Avoma adds roughly 3-10% to Gong's top line. That is a rounding error against a business growing organically. Contrast the ZoomInfo–Chorus deal in July 2021: ZoomInfo paid $575M for a business at roughly $150M ARR — approximately 13x — and that acquisition genuinely reshaped ZoomInfo's product surface and competitive position. Gong plus Avoma has no comparable effect on either.

Payback math. Model the acquisition honestly across 24 months on an Avoma base of, say, $40M ARR. Roughly 30-40% of customers might upgrade into Gong tiers, generating incremental ARR in the $5-30M range. Another 30-40% retain at current pricing. Somewhere between 15-25% churn during the transition — a realistic figure given that migration events are the single most reliable churn trigger in SaaS. A further 5-15% renegotiate downward. Net position after two years lands somewhere in the $15-45M net ARR range against a $150-300M purchase price. That's a 3-10 year payback depending entirely on where in the price band the deal lands and how flawlessly integration executes. The deal only pencils at the very bottom of the price range with near-perfect execution, which is a polite way of saying it doesn't pencil.

Retention dilution. Gong's net revenue retention is reported in the 115-130% range overall, with strategic accounts running meaningfully higher. Mid-market AI meeting assistants operate under different physics: gross churn in the 15-25% annual range is normal for that segment versus single-digit gross churn at enterprise, and NRR in the 90-105% band is typical. Fold a 90-105% NRR book into a 115-130% NRR business and the consolidated metric moves the wrong direction. For a company preparing an IPO narrative, NRR is not one metric among many — it is the metric public investors anchor on. Diluting it to add 5% of revenue is a bad trade in the boardroom and a worse one on a roadshow.

Unit economics don't translate. Avoma's motion is self-service and inside sales: free trial to paid, a 30-60 minute demo on the higher tiers, a two-week procurement cycle, CAC in the single-digit thousands, payback inside 12-18 months. Gong's motion is enterprise field sales: multi-stakeholder evaluation, security review, procurement, legal, 3-9 month cycles, CAC often in the tens of thousands or higher per logo, payback in the 18-30 month range against lifetime values in the millions. These are not two speeds of the same machine; they are two different machines. Running Avoma's motion inside Gong requires preserving a separate GTM org — separate comp plans, separate onboarding, separate support tiering, separate pricing governance — which is exactly the overhead that erodes the acquisition's margin contribution.

CRM mix works against cross-sell. Avoma's customer base skews substantially toward HubSpot, with Salesforce a meaningful but smaller share and the balance spread across Pipedrive, Zoho, and similar. Gong's installed base is overwhelmingly Salesforce. Cross-selling Gong into an Avoma book therefore demands investment in HubSpot-native Gong depth that Gong has historically deprioritized. The customer base Gong would be buying is concentrated precisely where Gong's integration story is weakest. That's not a synergy; it's a hidden line item.

The commoditization discount. The AI meeting assistant category is being squeezed from below by free and bundled options — Zoom's AI Companion, Microsoft Copilot inside Teams, Gemini in Google Meet — and from the side by aggressive freemium players like Fathom, Otter.ai, and Fireflies.ai. Meanwhile the underlying technology has commoditized: high-quality transcription is available to anyone via Whisper-class models and providers like AssemblyAI, and summarization quality across frontier models has converged. When the core capability is a commodity and the distribution is bundled into products every buyer already pays for, standalone pricing power erodes. Buying into that category in 2027 means buying an asset whose terminal value is declining while you own it.

What the same money buys elsewhere. $150-300M redirected: roughly $100M+ of incremental R&D toward revenue-intelligence AI agents over a 24-36 month horizon; $50M+ toward EMEA, APAC, and LATAM expansion where Gong is genuinely underweight and where local sales teams, partner ecosystems, and data-residency compliance are the actual bottleneck; $50M+ toward balance-sheet strength and IPO readiness. Or, on the M&A side, a Klue or Crayon acquisition in the $100-500M range that extends conversation intelligence into structured competitive intelligence — battlecards, win/loss, competitive content — for the same enterprise buyer Gong already sells to. That last one passes the decision tree Avoma fails: genuine capability gap, same customer, same price point, plausible payback.

Integration sequencing, if the answer were yes

Suppose the board overrules the analysis and Gong proceeds anyway. The failure modes of mid-size platform acquisitions are well documented, and sequencing determines whether the deal merely underperforms or actively destroys value. Here's how a competent integration would run — and reading it is itself an argument against the deal, because the operational load is heavy relative to what's being acquired.

Months 0-3: freeze and stabilize. Change nothing customer-facing. No pricing changes, no forced migrations, no product sunsets, no support-tier reshuffling. Announce continuity explicitly and publicly, because the moment an acquisition is announced every competitor's SDR team starts calling the acquired customer base with a "they're going to raise your price" script. Fathom, Fireflies, Otter, and Read.ai would all run that play within a week. Internally, this window is for retention agreements with key engineers, technical due diligence on the actual state of the codebase (which invariably differs from diligence-room representations), and mapping data models between the two platforms.

Months 3-9: dual-run and instrument. Keep both products fully operational. Build the telemetry that answers the only question that matters: which Avoma accounts show genuine Gong-tier signals? Look for revenue-team headcount growth, Salesforce adoption, enterprise security questionnaires, multi-team usage, and forecast-workflow engagement. That cohort — realistically 15-30% of the base — is the actual asset. Everyone else is a retention exercise, not an expansion opportunity.

Months 9-18: selective migration, never bulk. Migrate only the qualified cohort, one account at a time, with white-glove implementation and grandfathered pricing that steps up over 24-36 months rather than at renewal. Bulk migration is where these deals die: forced cutovers produce simultaneous churn spikes across a whole customer base and hand competitors a coordinated attack window. The rest of the base stays on the acquired product indefinitely, run as a maintained cash-generating line rather than a strategic priority.

Months 18-36: brand and platform decision. Only now decide whether the acquired product becomes a permanent SMB SKU, gets absorbed as a feature tier, or gets sunset with a long runway. Deciding this at close — which is the instinct — is what generates the churn. Deciding it with 18 months of usage telemetry is what preserves value.

Read that sequence and notice what it costs: three years of product, engineering, support, and GTM attention aimed at an asset contributing single-digit percentage points of revenue — during the exact window when a pre-IPO company needs its attention on margin discipline, S-1 preparation, and the AI agent roadmap that determines its multiple. Integration distraction is the tax nobody models in the deal memo, and here it's larger than the synergy.

The generalizable version, for RevOps teams inheriting a stack after any acquisition or merger: freeze, instrument, migrate selectively, decide late. The instinct to consolidate tooling fast is nearly always wrong. The systems your users chose deliberately are the ones that generate the most resistance when you take them away.

Timing, IPO discipline, and what Gong should do instead

The IPO overhang changes the calculus in ways easy to underweight. Gong last raised at a $7.25B valuation in June 2021 — the peak of a multiple environment that no longer exists. SaaS trading multiples compressed substantially from 2021 highs into the 2024-2025 norm, which means the relevant question isn't whether Gong is worth $7.25B in private-round terms but what a public market will pay against current comparables. In that environment, every pre-IPO dollar gets scrutinized for whether it produced proportionate growth, margin improvement, or defensible positioning. An acquisition that adds modest revenue, dilutes NRR, and consumes three years of integration attention scores poorly on all three.

There's also a straightforward timing argument. Strategic M&A in the 12-18 months immediately before an IPO is typically minimized precisely because S-1 preparation, auditor review, roadshow, and pricing consume the same executive bandwidth that integration demands. If the IPO window is 2026-2027, the plausible M&A windows are 2025 or post-IPO 2028 — not the middle. Timing alone argues against a 2027 transaction regardless of the target.

So what should Gong actually do with the capital and the attention?

AI agents first. The differentiated bet is agents that act rather than report: autonomous deal review that flags risk before the manager asks, coaching plan generation tuned to an individual rep's conversation patterns, forecast adjustment that reconciles CRM optimism against what customers actually said, next-best-action recommendations grounded in a decade of conversation data. This is where Gong's data moat converts into product advantage, and it's the investment most likely to defend the multiple through an IPO.

Vertical AI second. Healthcare conversation intelligence with PHI handling, financial services with regulatory recording obligations, pharma, legal. Each vertical is a slower build than horizontal features but produces pricing power that horizontal AI meeting assistants structurally cannot match. Avoma contributes nothing here.

International third. EMEA, APAC, and LATAM expansion is a distribution problem — local sales teams, partner ecosystems, language coverage, data residency and privacy compliance — and it's solved with headcount and infrastructure, not with an acquisition of a US mid-market vendor.

M&A fourth, and only for real strategic moves. If ZoomInfo ever divests Chorus under pressure, a buyback consolidates the enterprise conversation-intelligence category in Gong's favor and removes the most credible direct competitor — that's a strategically meaningful transaction at a plausible price. A competitive-intelligence tuck-in extends the platform for the same enterprise buyer. And a combination with a sales-engagement platform would be genuinely transformational, creating a unified revenue platform at combined scale that neither company reaches alone. Those are the deals worth corp-dev's calendar. Avoma isn't.

What likely happens to Avoma. The most probable outcome is continued independence, navigating commoditization pressure from free and bundled alternatives. If it does get acquired, the logical buyers are consolidators in its own category — Otter.ai as the largest player by user count — or a platform where the strategic fit is genuinely additive: HubSpot, given Avoma's HubSpot-heavy base, or Salesforce, given Slack's AI meeting ambitions. Gong is not on that list, and shouldn't be. Reasonable estimates put the probability Gong acquires Avoma by end of 2027 in the single digits to low teens, against a meaningfully higher probability Avoma is acquired by someone.

The broader RevOps takeaway travels well past this one deal. When a vendor consolidation is proposed — at the corp-dev level or at the level of a revenue team deciding whether to buy a point solution — run the same three tests. Does it fill a genuine capability gap, or duplicate one you have? Is the acquired user base structurally similar to the one you serve, or did they self-select away from you on price? And does the payback survive honest churn assumptions rather than optimistic ones? Deals that fail all three tests still close regularly, usually because the strategic story is more emotionally satisfying than the arithmetic. The discipline is in preferring the arithmetic.

Related questions

Would acquiring Chorus back from ZoomInfo make more sense for Gong?

Strategically, yes — meaningfully more. Chorus serves enterprise customers, the product is mature, and the acquisition would remove Gong's most credible direct competitor while consolidating the enterprise tier. It depends entirely on whether ZoomInfo ever chooses to divest, which is far from certain.

Should mid-market companies choose Avoma over Gong?

Often yes. If your revenue team is 10-50 reps, you need transcription, summaries, CRM sync, and light coaching, and enterprise pricing is out of reach, a mid-market AI meeting assistant is the right call. Gong's value concentrates in enterprise deal complexity you may not have.

What happens to conversation intelligence pricing as AI commoditizes?

Standalone transcription and summarization pricing trends toward zero, squeezed by free tiers and bundling inside Zoom, Teams, and Meet. Durable pricing power moves to what sits above the transcript: forecasting accuracy, deal risk detection, coaching workflows, and vertical compliance.

How should RevOps evaluate any vendor-consolidation proposal?

Map capability overlap honestly, identify what's genuinely additive, price only that increment, then model payback with pessimistic churn assumptions. If overlap exceeds roughly 70% or the user base self-selected away from your platform on price, the consolidation usually destroys more value than it creates.

Does Gong need an SMB product at all?

Arguably yes, eventually — but building a lighter tier is cheaper and cleaner than buying one. A build gives Gong a single codebase, a single data model, and pricing governance it controls, without inheriting a separate GTM motion or a churn-prone installed base.

FAQ

Why is product overlap the deciding factor rather than price?

Because overlap determines whether any price is defensible. When roughly 80% of the acquired capability already exists in your platform, you're paying primarily for a customer list and headcount. Both can be obtained more cheaply — customers through go-to-market investment, engineers through direct hiring. Price only becomes the interesting variable once there's a genuine capability gap to value.

Isn't buying the mid-market customer base worth something on its own?

Less than it appears. Those customers evaluated enterprise-tier conversation intelligence and deliberately chose a lower price point. That revealed preference doesn't reverse post-close. Realistic modeling puts perhaps 15-30% as genuine upgrade candidates, with 15-25% churning during any transition. You're buying a retention obligation with a modest expansion option attached.

Would the acquisition hurt Gong's IPO narrative?

Likely, yes. Mid-market conversation intelligence carries structurally lower net revenue retention than enterprise, so folding that book in dilutes the consolidated NRR figure that public investors anchor on. Adding roughly 5% to revenue while weakening the headline retention metric is an unfavorable trade during exactly the window when that metric is under maximum scrutiny.

What would change the answer to yes?

A materially lower price — call it the bottom of the range or below, at a distressed multiple. Or evidence that Gong's enterprise growth is decelerating enough that mid-market expansion becomes strategically necessary rather than opportunistic. Or a credible threat that a category consolidator is about to build a genuine enterprise on-ramp from below. None of those conditions is clearly present.

How does the commoditization of transcription affect the valuation?

Substantially. When high-quality transcription is available through commodity models and summarization quality has converged across frontier providers, the technical moat around an AI meeting assistant collapses. What remains is distribution and workflow depth. Paying a strategic multiple for an asset whose core capability is commoditizing means buying something whose terminal value declines while you own it.

What's the strongest argument on the other side?

Defensive consolidation. If a well-capitalized category leader assembles the mid-market AI meeting assistant space and uses it to build an on-ramp into enterprise accounts, Gong faces competitive compression from below over a five-year horizon. That's a real risk — but the appropriate response is a lighter-weight Gong tier built in-house, not a $150-300M acquisition with a decade-long payback.

Sources

• https://www.crunchbase.com/organization/gong-io
• https://www.crunchbase.com/organization/avoma
• https://ir.zoominfo.com/news-events/press-releases
• https://techcrunch.com/tag/gong/
• https://www.sec.gov/edgar/searchedgar/companysearch
• https://news.crunchbase.com/sections/ma/
• https://www.gartner.com/reviews/market/revenue-intelligence-platforms
• https://www.g2.com/categories/conversation-intelligence
• https://www.bvp.com/atlas/state-of-the-cloud
• https://www.finra.org/rules-guidance

Related on PULSE

• [How should RevOps evaluate a vendor consolidation proposal?](/knowledge.html?q=revops-vendor-consolidation-evaluation)
• [What is revenue intelligence and how does it differ from conversation intelligence?](/knowledge.html?q=revenue-intelligence-vs-conversation-intelligence)
• [How do you migrate a revenue team off a legacy sales tool without churning users?](/knowledge.html?q=migrate-revenue-team-legacy-tool)
• [What metrics do public market investors scrutinize in a SaaS IPO?](/knowledge.html?q=saas-ipo-metrics-investors-scrutinize)
• [Should you buy a point solution or extend your existing revenue platform?](/knowledge.html?q=point-solution-vs-platform-extension)
• [How does AI commoditization change B2B SaaS pricing power?](/knowledge.html?q=ai-commoditization-saas-pricing-power)